Global Haemato Oncology Testing Market Research Report 2023

Haemato Oncology Testing Market

According to new survey, global Haemato Oncology Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Haemato Oncology Testing market research.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Haemato Oncology Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Haemato Oncology Testing Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Haemato Oncology Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Leukaemia

1.2.3 Lymphoma

1.2.4 Hodgkin Lymphoma

1.2.5 Others

1.3 Market by Application

1.3.1 Global Haemato Oncology Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinical Laboratories

1.3.3 Hospitals

1.3.4 Academic and Research Institutes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Haemato Oncology Testing Market Perspective (2018-2029)

2.2 Haemato Oncology Testing Growth Trends by Region

2.2.1 Global Haemato Oncology Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Haemato Oncology Testing Historic Market Size by Region (2018-2023)

2.2.3 Haemato Oncology Testing Forecasted Market Size by Region (2024-2029)

2.3 Haemato Oncology Testing Market Dynamics

2.3.1 Haemato Oncology Testing Industry Trends

2.3.2 Haemato Oncology Testing Market Drivers

2.3.3 Haemato Oncology Testing Market Challenges

2.3.4 Haemato Oncology Testing Market Restraints

3.1 Global Top Haemato Oncology Testing Players by Revenue

3.1.1 Global Top Haemato Oncology Testing Players by Revenue (2018-2023)

3.1.2 Global Haemato Oncology Testing Revenue Market Share by Players (2018-2023)

3.2 Global Haemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Haemato Oncology Testing Revenue

3.4 Global Haemato Oncology Testing Market Concentration Ratio

3.4.1 Global Haemato Oncology Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Haemato Oncology Testing Revenue in 2022

3.5 Haemato Oncology Testing Key Players Head office and Area Served

3.6 Key Players Haemato Oncology Testing Product Solution and Service

3.7 Date of Enter into Haemato Oncology Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Haemato Oncology Testing Historic Market Size by Type (2018-2023)

4.2 Global Haemato Oncology Testing Forecasted Market Size by Type (2024-2029)

5.1 Global Haemato Oncology Testing Historic Market Size by Application (2018-2023)

5.2 Global Haemato Oncology Testing Forecasted Market Size by Application (2024-2029)

6.1 North America Haemato Oncology Testing Market Size (2018-2029)

6.2 North America Haemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Haemato Oncology Testing Market Size by Country (2018-2023)

6.4 North America Haemato Oncology Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Haemato Oncology Testing Market Size (2018-2029)

7.2 Europe Haemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Haemato Oncology Testing Market Size by Country (2018-2023)

7.4 Europe Haemato Oncology Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Haemato Oncology Testing Market Size (2018-2029)

8.2 Asia-Pacific Haemato Oncology Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Haemato Oncology Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific Haemato Oncology Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Haemato Oncology Testing Market Size (2018-2029)

9.2 Latin America Haemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Haemato Oncology Testing Market Size by Country (2018-2023)

9.4 Latin America Haemato Oncology Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Haemato Oncology Testing Market Size (2018-2029)

10.2 Middle East & Africa Haemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Haemato Oncology Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa Haemato Oncology Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Haemato Oncology Testing Introduction

11.1.4 Roche Revenue in Haemato Oncology Testing Business (2018-2023)

11.1.5 Roche Recent Development

11.2 Berry Genomics

11.2.1 Berry Genomics Company Detail

11.2.2 Berry Genomics Business Overview

11.2.3 Berry Genomics Haemato Oncology Testing Introduction

11.2.4 Berry Genomics Revenue in Haemato Oncology Testing Business (2018-2023)

11.2.5 Berry Genomics Recent Development

11.3 Burning Rock Dx

11.3.1 Burning Rock Dx Company Detail

11.3.2 Burning Rock Dx Business Overview

11.3.3 Burning Rock Dx Haemato Oncology Testing Introduction

11.3.4 Burning Rock Dx Revenue in Haemato Oncology Testing Business (2018-2023)

11.3.5 Burning Rock Dx Recent Development

11.4 BGI

11.4.1 BGI Company Detail

11.4.2 BGI Business Overview

11.4.3 BGI Haemato Oncology Testing Introduction

11.4.4 BGI Revenue in Haemato Oncology Testing Business (2018-2023)

11.4.5 BGI Recent Development

11.5 Genetron

11.5.1 Genetron Company Detail

11.5.2 Genetron Business Overview

11.5.3 Genetron Haemato Oncology Testing Introduction

11.5.4 Genetron Revenue in Haemato Oncology Testing Business (2018-2023)

11.5.5 Genetron Recent Development

11.6 Haplox

11.6.1 Haplox Company Detail

11.6.2 Haplox Business Overview

11.6.3 Haplox Haemato Oncology Testing Introduction

11.6.4 Haplox Revenue in Haemato Oncology Testing Business (2018-2023)

11.6.5 Haplox Recent Development

11.7 Amoy Dx

11.7.1 Amoy Dx Company Detail

11.7.2 Amoy Dx Business Overview

11.7.3 Amoy Dx Haemato Oncology Testing Introduction

11.7.4 Amoy Dx Revenue in Haemato Oncology Testing Business (2018-2023)

11.7.5 Amoy Dx Recent Development

11.8 Genosaber

11.8.1 Genosaber Company Detail

11.8.2 Genosaber Business Overview

11.8.3 Genosaber Haemato Oncology Testing Introduction

11.8.4 Genosaber Revenue in Haemato Oncology Testing Business (2018-2023)

11.8.5 Genosaber Recent Development

11.9 YZY Biopharma

11.9.1 YZY Biopharma Company Detail

11.9.2 YZY Biopharma Business Overview

11.9.3 YZY Biopharma Haemato Oncology Testing Introduction

11.9.4 YZY Biopharma Revenue in Haemato Oncology Testing Business (2018-2023)

11.9.5 YZY Biopharma Recent Development

11.10 Wondfo

11.10.1 Wondfo Company Detail

11.10.2 Wondfo Business Overview

11.10.3 Wondfo Haemato Oncology Testing Introduction

11.10.4 Wondfo Revenue in Haemato Oncology Testing Business (2018-2023)

11.10.5 Wondfo Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Haemato Oncology Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Leukaemia

    Table 3. Key Players of Lymphoma

    Table 4. Key Players of Hodgkin Lymphoma

    Table 5. Key Players of Others

    Table 6. Global Haemato Oncology Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Haemato Oncology Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Haemato Oncology Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Haemato Oncology Testing Market Share by Region (2018-2023)

    Table 10. Global Haemato Oncology Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Haemato Oncology Testing Market Share by Region (2024-2029)

    Table 12. Haemato Oncology Testing Market Trends

    Table 13. Haemato Oncology Testing Market Drivers

    Table 14. Haemato Oncology Testing Market Challenges

    Table 15. Haemato Oncology Testing Market Restraints

    Table 16. Global Haemato Oncology Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Haemato Oncology Testing Market Share by Players (2018-2023)

    Table 18. Global Top Haemato Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemato Oncology Testing as of 2022)

    Table 19. Ranking of Global Top Haemato Oncology Testing Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Haemato Oncology Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Haemato Oncology Testing Product Solution and Service

    Table 23. Date of Enter into Haemato Oncology Testing Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Haemato Oncology Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Haemato Oncology Testing Revenue Market Share by Type (2018-2023)

    Table 27. Global Haemato Oncology Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Haemato Oncology Testing Revenue Market Share by Type (2024-2029)

    Table 29. Global Haemato Oncology Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Haemato Oncology Testing Revenue Market Share by Application (2018-2023)

    Table 31. Global Haemato Oncology Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Haemato Oncology Testing Revenue Market Share by Application (2024-2029)

    Table 33. North America Haemato Oncology Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Haemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Haemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Haemato Oncology Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Haemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Haemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Haemato Oncology Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Haemato Oncology Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Haemato Oncology Testing Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Haemato Oncology Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Haemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Haemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Haemato Oncology Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Haemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Haemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Roche Company Detail

    Table 49. Roche Business Overview

    Table 50. Roche Haemato Oncology Testing Product

    Table 51. Roche Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 52. Roche Recent Development

    Table 53. Berry Genomics Company Detail

    Table 54. Berry Genomics Business Overview

    Table 55. Berry Genomics Haemato Oncology Testing Product

    Table 56. Berry Genomics Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 57. Berry Genomics Recent Development

    Table 58. Burning Rock Dx Company Detail

    Table 59. Burning Rock Dx Business Overview

    Table 60. Burning Rock Dx Haemato Oncology Testing Product

    Table 61. Burning Rock Dx Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 62. Burning Rock Dx Recent Development

    Table 63. BGI Company Detail

    Table 64. BGI Business Overview

    Table 65. BGI Haemato Oncology Testing Product

    Table 66. BGI Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 67. BGI Recent Development

    Table 68. Genetron Company Detail

    Table 69. Genetron Business Overview

    Table 70. Genetron Haemato Oncology Testing Product

    Table 71. Genetron Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 72. Genetron Recent Development

    Table 73. Haplox Company Detail

    Table 74. Haplox Business Overview

    Table 75. Haplox Haemato Oncology Testing Product

    Table 76. Haplox Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 77. Haplox Recent Development

    Table 78. Amoy Dx Company Detail

    Table 79. Amoy Dx Business Overview

    Table 80. Amoy Dx Haemato Oncology Testing Product

    Table 81. Amoy Dx Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 82. Amoy Dx Recent Development

    Table 83. Genosaber Company Detail

    Table 84. Genosaber Business Overview

    Table 85. Genosaber Haemato Oncology Testing Product

    Table 86. Genosaber Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 87. Genosaber Recent Development

    Table 88. YZY Biopharma Company Detail

    Table 89. YZY Biopharma Business Overview

    Table 90. YZY Biopharma Haemato Oncology Testing Product

    Table 91. YZY Biopharma Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 92. YZY Biopharma Recent Development

    Table 93. Wondfo Company Detail

    Table 94. Wondfo Business Overview

    Table 95. Wondfo Haemato Oncology Testing Product

    Table 96. Wondfo Revenue in Haemato Oncology Testing Business (2018-2023) & (US$ Million)

    Table 97. Wondfo Recent Development

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Haemato Oncology Testing Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Haemato Oncology Testing Market Share by Type: 2022 VS 2029

    Figure 3. Leukaemia Features

    Figure 4. Lymphoma Features

    Figure 5. Hodgkin Lymphoma Features

    Figure 6. Others Features

    Figure 7. Global Haemato Oncology Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Haemato Oncology Testing Market Share by Application: 2022 VS 2029

    Figure 9. Clinical Laboratories Case Studies

    Figure 10. Hospitals Case Studies

    Figure 11. Academic and Research Institutes Case Studies

    Figure 12. Others Case Studies

    Figure 13. Haemato Oncology Testing Report Years Considered

    Figure 14. Global Haemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Haemato Oncology Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Haemato Oncology Testing Market Share by Region: 2022 VS 2029

    Figure 17. Global Haemato Oncology Testing Market Share by Players in 2022

    Figure 18. Global Top Haemato Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemato Oncology Testing as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Haemato Oncology Testing Revenue in 2022

    Figure 20. North America Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Haemato Oncology Testing Market Share by Country (2018-2029)

    Figure 22. United States Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Haemato Oncology Testing Market Share by Country (2018-2029)

    Figure 26. Germany Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Haemato Oncology Testing Market Share by Region (2018-2029)

    Figure 34. China Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Haemato Oncology Testing Market Share by Country (2018-2029)

    Figure 42. Mexico Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Haemato Oncology Testing Market Share by Country (2018-2029)

    Figure 46. Turkey Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Haemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Roche Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 49. Berry Genomics Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 50. Burning Rock Dx Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 51. BGI Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 52. Genetron Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 53. Haplox Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 54. Amoy Dx Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 55. Genosaber Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 56. YZY Biopharma Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 57. Wondfo Revenue Growth Rate in Haemato Oncology Testing Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed